Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?

Abbott has gained U.S. Food and Drug Administration (FDA) approval for its Navitor transcatheter aortic valve replacement (TAVR) system, the company’s new self-expanding valve for high-risk patients with severe symptomatic aortic stenosis.

Abbott receives FDA approval for new self-expanding TAVR system

The device, which gained CE mark approval in Europe in May 2021, features a new-look fabric cuff designed to keep the risk of paravalvular leak (PVL) at a minimum.

Fysicon’s QMAPP Hemodynamic Monitoring Device

Canon Medical Systems announces new partnership focused on enterprise imaging and hemodynamics

The partnership is with ScImage, a California-based healthcare technology company known for its extensive EI background.

How cardiologists can improve in-hospital outcomes after PCI

Researchers evaluated if two recently developed risk scores can anticipate adverse in-hospital outcomes after PCI, sharing their findings in the American Journal of Cardiology.

A new antiplatelet strategy for treating diabetic PCI patients

Clopidogrel monotherapy after just one month of DAPT was associated with promising outcomes, including a reduction in bleeding events.

Elevated uric acid levels linked to new-onset AFib

According to new data published in the Journal of the American Heart Association, atrial fibrillation can be added to the list of cardiovascular conditions associated with above-average uric acid levels.

How intravascular lithotripsy can improve TMVR outcomes

The IVL technology developed by Shockwave Medical helped clinicians treat a TMVR patient who had previously undergone TAVR. Could this be a common use of IVL in the future?

Jakob Weiss, MD, a radiologist affiliated with the Cardiovascular Imaging Research Center at Massachusetts General Hospital and the AI in Medicine program at the Brigham and Women’s Hospital in Boston, helped develop an deep learning AI algorithm that can assess a patient's biological age and risk assess patients for various diseases. #RSNA #AI #ImagingAI

VIDEO: AI predicts heart disease risk using single chest X-ray

Jakob Weiss, MD, was the lead author on a study that used AI to determine a patient's cardiovascular risks based on a standard chest X-ray.

Medtronic enrolls first patient for head-to-head EVAR study

The randomized trial, expected to enroll at least 550 patients, will follow patients for a total of five years.

Cardiac Imaging

Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Family of heart patient who died awarded $45M after suing health system for negligence

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women